Arbor Biotechnologies

Arbor Biotechnologies, founded as a life sciences company, is dedicated to pushing the boundaries of biodiscovery. Their core mission is to revolutionize the treatment of genetic diseases by developing next-generation gene editing tools. Utilizing a diverse set of technologies, including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, Arbor focuses on creating innovative solutions to address the root causes of genetic disorders.

Notable affiliated individuals include co-founders Feng Zhang and David Walt, both prominent figures in biotechnology. Arbor has garnered significant investment from leading venture capital firms, bolstering its research and development capabilities. Key achievements include the development of a diverse toolbox of novel gene editors, positioning Arbor at the forefront of genetic disease treatment. The company's impact lies in its potential to deliver functional cures for previously untreatable genetic conditions, marking a significant advancement in personalized medicine.